Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KALAHARI: Long-Term Safety of NOV03 in Dry Eye Disease
NCT04140227Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perfluorohexyloctane in dry eye disease (DED), sponsored by Bausch + Lomb. Started Sep 2020; status: completed.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04140227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140227.